01 1Zibo Xinhua Perrigo Pharmaceutical
01 1IBUPROFEN USP DRUG SUBSTANCE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-10-21
Pay. Date : 2020-10-16
DMF Number : 18413
Submission : 2005-06-09
Status : Active
Type : II
20
Zibo Xinhua Perrigo Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IBUPROFEN USP DRUG SUBSTANCE, with a corresponding US DMF Number 18413.
Remarkably, this DMF maintains an Active status since its submission on June 09, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 21, 2020, and payment made on October 16, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
